A part of Merck

MAB5680 | Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody

100 µg  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Al finalizar el pedido Más información
Ahorró ()
Solicitar precio
Disponibilidad a confirmarDisponibilidad a confirmar
En existencia 
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente

      Ofertas especiales


      Póngase en contacto con el Servicio de Atención al Cliente

      Click To Print This Page


      Replacement Information

      Ofertas especiales

      Tabla espec. clave

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      M, R FC, ICC, IHC, WB M Purified Monoclonal Antibody
      Catalogue NumberMAB5680
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody
      Alternate Names
      • MOG
      Background InformationMyelin oligodendrocyte glycoprotein (MOG) is a key CNS-specific autoantigen for primary demyelination in multiple sclerosis. Although the disease-inducing role of MOG has been established, its precise function in the CNS remains obscure. MOG is a type I integral membrane protein possessing a single extracellular Ig variable domain (Ig-V) (3, 13, 14). The amino acid sequence of MOG is highly conserved among animal species (>90%), indicative of an important biological function. MOG is specifically expressed in the CNS on the outermost lamellae of the myelin sheath as well as the cell body and processes of oligodendrocytes. The developmentally late expression of MOG correlates with the later stages of myelinogenesis, suggesting that MOG has a role in the completion, compaction, and/or maintenance of myelin, further suggesting that MOG has an adhesive function within the CNS . Consistent with MOG's possible adhesive role in the CNS, a homodimeric form of MOG has not only been observed after isolation from the CNS but has additionally been observed in situ.
      Product Information
      • brain lysate
      PresentationPurified in PBS with 0.05% NaN3.
      ApplicationAnti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody is an antibody against Myelin Oligodendrocyte Glycoprotein (MOG) for use in FC, IC, IH & WB.
      Key Applications
      • Flow Cytometry
      • Immunocytochemistry
      • Immunohistochemistry
      • Western Blotting
      Biological Information
      ImmunogenRat cerebellar glycoproteins
      EpitopeThe antibody binds to a discontinuous epitope present on the extracellular immunoglobulin V-like domain of MOG.
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      SpecificityMembane associated region of MOG [Myelin oligodendrocyte glycoprotein].
      Species Reactivity
      • Mouse
      • Rat
      Species Reactivity NoteMay cross react with human and bovine based on sequence similarity.
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Purification MethodPurified immunoglobulin
      UniProt Number
      UniProt SummaryFUNCTION: Minor component of the myelin sheath. May be involved in completion and/or maintenance of the myelin sheath and in cell-cell communication.
      SUBUNIT: May form homodimers.
      SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
      TISSUE SPECIFICITY: Found exclusively in the CNS, where it is localized on the surface of myelin and oligodendrocyte cytoplasmic membranes.
      DEVELOPMENTAL STAGE: A peak of expression has been observed between postnatal days 15 and 25, coinciding with the period of active myelination.
      SIMILARITY: Belongs to the immunoglobulin superfamily. BTN/MOG family.
      SIMILARITY: Contains 1 Ig-like V-type (immunoglobulin-like) domain.
      CAUTION: Do not confuse myelin-oligodendrocyte glycoprotein (MOG) with oligodendrocyte-myelin glycoprotein (OMG).
      Molecular Weight28 kDa
      Physicochemical Information
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceRoutinely evaluated by immunoblot.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain at 2-8°C in undiluted aliquots for up to 1 year after date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information


      Ficha datos de seguridad (MSDS)


      Ficha técnica de seguridad del material (MSDS) 

      Certificados de análisis

      CargoNúmero de lote
      Anti-MOG, Clone 8-18C5 - 2116701 2116701
      Anti-MOG, Clone 8-18C5 - 2146016 2146016
      Anti-MOG, Clone 8-18C5 - 2366606 2366606
      Anti-MOG, Clone 8-18C5 - NG2452527 NG2452527
      Anti-MOG, Clone 8-18C5 - 1975956 1975956
      Anti-MOG, Clone 8-18C5 - 2020314 2020314
      Anti-MOG, Clone 8-18C5 - 2224500 2224500
      Anti-MOG, Clone 8-18C5 - 2291701 2291701
      Anti-MOG, Clone 8-18C5 - 2491187 2491187
      Anti-MOG, Clone 8-18C5 - JBC1793804 JBC1793804
      Anti-MOG, Clone 8-18C5 - LV1555747 LV1555747
      Anti-MOG, Clone 8-18C5 - NG1522924 NG1522924
      Anti-MOG, Clone 8-18C5 - NG1681846 NG1681846
      Anti-MOG, Clone 8-18C5 - NG1710276 NG1710276
      Anti-MOG, Clone 8-18C5 - NG1734229 NG1734229
      Anti-MOG, Clone 8-18C5 - NG1754174 NG1754174
      Anti-MOG, Clone 8-18C5 - NG1811789 NG1811789
      Anti-MOG, Clone 8-18C5 - NG1848907 NG1848907
      Anti-MOG, Clone 8-18C5 - NG1884023 NG1884023
      Anti-MOG, Clone 8-18C5 - NG1917784 NG1917784
      Anti-MOG, Clone 8-18C5 -2551206 2551206
      Anti-MOG, Clone 8-18C5 -2575903 2575903
      Anti-MOG, Clone 8-18C5 -2606334 2606334
      Anti-MOG, Clone 8-18C5 -2654340 2654340
      Anti-MOG, Clone 8-18C5 -2701017 2701017
      Anti-MOG, Clone 8-18C5 -2780481 2780481
      Anti-MOG, Clone 8-18C5 Monoclonal Antibody_2814766 2814766

      Referencias bibliográficas

      Visión general referenciasPub Med ID
      Oligodendroglial maturation is dependent on intracellular protein shuttling.
      Göttle, P; Sabo, JK; Heinen, A; Venables, G; Torres, K; Tzekova, N; Parras, CM; Kremer, D; Hartung, HP; Cate, HS; Küry, P
      The Journal of neuroscience : the official journal of the Society for Neuroscience 35 906-19 2015

      Mostrar resumen
      25609610 25609610
      Fingolimod attenuates splenocyte-induced demyelination in cerebellar slice cultures.
      Pritchard, AJ; Mir, AK; Dev, KK
      PloS one 9 e99444 2014

      Mostrar resumen
      24911000 24911000
      Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.
      Najm, FJ; Lager, AM; Zaremba, A; Wyatt, K; Caprariello, AV; Factor, DC; Karl, RT; Maeda, T; Miller, RH; Tesar, PJ
      Nature biotechnology 31 426-33 2013

      Mostrar resumen
      23584611 23584611
      M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
      Miron, VE; Boyd, A; Zhao, JW; Yuen, TJ; Ruckh, JM; Shadrach, JL; van Wijngaarden, P; Wagers, AJ; Williams, A; Franklin, RJ; ffrench-Constant, C
      Nature neuroscience 16 1211-8 2013

      Mostrar resumen
      23872599 23872599

      Licencias necesarias e Información técnica

      Derivation of oligodendrocyte progenitor cells from a human neural stem cell line

      Newsletters / Publications

      Cellutions - The newsletter for Cell Biology Researchers Volume 3: 2011